Sanofi
SEC Form 4 insider trading activity
Sanofi has filed 2 SEC Form 4 filings (4 transaction rows) across 2 companies, including LTGO, ATTO, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 12, 2026.
On the most recent filing, Sanofi is listed as 10% Owner at Attovia Therapeutics, Inc. Inside the rolling window, Sanofi reported 1 open-market purchase totaling $5.1M in ATTO and no open-market sales.
Companies traded
Other insiders at LTGO
Insider Buying
$5.1M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Sanofi made?
Sanofi has filed 2 SEC Form 4 filings (4 transaction rows) across 2 companies, including LTGO, ATTO since 2026.
Which companies does Sanofi trade?
Sanofi has filed SEC Form 4 disclosures for 2 companies, including LTGO, ATTO.
When was Sanofi's most recent SEC Form 4 filing?
Sanofi's most recent SEC Form 4 filing on Tracefour is dated Aug 12, 2026.
What is Sanofi's total buy and sell value in the current window?
Inside the rolling retention window, Sanofi bought $5.1M and sold $0 based on SEC Form 4 filings.
What was Sanofi's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 300,000 ATTO shares on 2026-08-06, worth $5.1M, per SEC Form 4 filings.